
Luke Laffin, MD, FACC, is a preventive cardiologist and academic physician specializing in complex blood pressure disorders and cardiovascular risk reduction. He serves as Co-Director of the Center for Blood Pressure Disorders and Medical Director of Cardiac Rehabilitation at Cleveland Clinic’s main campus, and is an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. His clinical practice focuses on comprehensive blood pressure evaluation and monitoring, preventive cardiology with advanced risk-factor optimization, and cardiac rehabilitation with individualized lifestyle and medication strategies. His research interests include gene-editing and other innovative therapies targeting lipid metabolism, next-generation pharmacotherapy for difficult-to-control blood pressure, and methods to improve clinical trial generalizability for real-world patient care. Dr. Laffin is a late-breaking presenter at ACC.26 and has been recognized for excellence in medical education with the Rory R. Childers Cardiology Teaching Award. He also contributes to the broader cardiovascular community through leadership and advisory roles, including service on the Clinical Trials Transformation Initiative Steering Committee and the Medical Advisory Board of Blend Health Technologies. He earned his MD from Vanderbilt University School of Medicine, completed an Internal Medicine residency at the University of Chicago Medical Center, and completed fellowships in Hypertension and Cardiovascular Disease at the University of Chicago.
Associate Professor
Medical School
2007 – 2011
Residency
2011 – 2014
Fellowship
2014 – 2015